Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Glaucoma in perspective

Astellas wins US approval for prostate cancer drug Xtandi

Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer

- PMLiVE

Lilly appoints Michael Harrington SVP and general counsel

Replaces Robert Armitage who retires from the pharma company

- PMLiVE

Best practice in regulatory outsourcing: top tips

Outsourcing is not without its risk, but if you get it right the rewards for your business can be significant

- PMLiVE

J&J to pay $181m to settle Risperdal off-label promotion lawsuits in the US

Company's Janssen subsidiary looks to draw a line under mis-marketing claims filed in 36 US states

Havas appoints Ben Davies as European CEO

He will take over from Ed Stapor at the healthcare communications agency

- PMLiVE

J&J signs $1.1bn deal with Genmab for cancer antibody

Licenses daratumumab in development for multiple myeloma

AstraZeneca taps social media for employee wellness drive

Interactive ‘Shape Up’ website offers staff chance to track their health and fitness

- PMLiVE

Bayer files regorafenib for GIST in US

Follows priority review for drug in metastatic colorectal cancer

- PMLiVE

FDA approves Teva’s biosimilar for neutropaenia in cancer patients

Neupogen biosimilar already marketed in Europe as Tevagrastim

- PMLiVE

Galectin Therapuetics appoints Harold Shlevin as chief operating officer

Will replace company co-founder Maureen Foley

Publicis to Merge Razorfish and Healthware International

Publicis is to merge its two digital agencies, Razorfish and Publicis Healthware International. The new enterprise will be called Razorfish Healthware as of immediate effect

- PMLiVE

Abbott’s Humira receives expanded Crohn’s disease indication in Europe

Also receives FDA panel backing in ulcerative colitis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links